← Back to Search

Inhaled Isopropyl Alcohol vs Eucalyptus for Migraine-Related Nausea

N/A
Recruiting
Led By Jill Rau, MD, PhD
Research Sponsored by HonorHealth Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients 18 to 65 years old with nausea associated migraines at least twice per month
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ½ hour or to the end of treatment
Awards & highlights

Study Summary

This trial is testing if breathing in isopropyl alcohol can relieve nausea from migraines better than a placebo.

Who is the study for?
This trial is for adults aged 18 to 65 who experience nausea with their migraines at least twice a month. It's not suitable for those under 18 or over 65, or patients without an acute migraine diagnosis.Check my eligibility
What is being tested?
The study aims to see if inhaling isopropyl alcohol vapors (IAV) is more effective and safer than a placebo, which in this case is diluted eucalyptus oil scent (IES), for relieving nausea during acute migraine attacks.See study design
What are the potential side effects?
Potential side effects may include irritation of the airways, headaches, dizziness, or allergic reactions from inhaling the substances used in the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old and get migraines with nausea at least twice a month.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~½ hour, but likely less than 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and ½ hour, but likely less than 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change of Severity of Nausea on Nausea Scale
Secondary outcome measures
Side effects associated with interventional substance
Time to Clinically Relevant Nausea Change
Use of anti-nausea medication/Time to use of anti-nausea medication

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Isopropyl Alcohol VaporsActive Control1 Intervention
Isopropyl Alcohol 70%
Group II: Eucalyptus Oil ScentPlacebo Group1 Intervention
Eucalyptus oil diluted in mineral oil 1:20

Find a Location

Who is running the clinical trial?

HonorHealth Research InstituteLead Sponsor
25 Previous Clinical Trials
856 Total Patients Enrolled
Jill Rau, MD, PhDPrincipal InvestigatorHonorHealth Research Institute

Media Library

Isopropyl Alcohol Vapors Clinical Trial Eligibility Overview. Trial Name: NCT05175521 — N/A
Migraine Research Study Groups: Isopropyl Alcohol Vapors, Eucalyptus Oil Scent
Migraine Clinical Trial 2023: Isopropyl Alcohol Vapors Highlights & Side Effects. Trial Name: NCT05175521 — N/A
Isopropyl Alcohol Vapors 2023 Treatment Timeline for Medical Study. Trial Name: NCT05175521 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrolment rate for this clinical research?

"Affirmative. Clinicaltrials.gov details that this clinical trial, initially posted on November 11th 2021 is actively seeking participants. 50 patients need to be enrolled at a single medical centre."

Answered by AI

Does this research involve any participants aged eighty or above?

"According to the trial's eligibility criteria, applicants between 18 and 65 are qualified for this investigation. Notably, there are 43 studies available specifically for minors, while 171 trials target patients who have surpassed 65 years old."

Answered by AI

Are there still available slots in this clinical research project?

"Per the details provided on clinicaltrials.gov, this research study is actively seeking participants. It was initially shared to the public domain on November 11th 2021 and has since been refreshed on December 27th of that same year."

Answered by AI

Am I eligible to participate in this research venture?

"This research endeavour is accepting 50 people with migraine between 18 and 65 years old. Applicants must meet the following criteria: Patients aged 18 to 65 who experience nausea associated migraines at least bi-monthly."

Answered by AI
~5 spots leftby Jul 2024